Impact of Lipid-Lowering Therapy on Glycemic Control and the Risk for New-Onset Diabetes Mellitus

Drugs in Context - United Kingdom
doi 10.7573/dic.212562
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BioExcel

Related search

New Strategies of Insulin Therapy - A Way to Effective Glycemic Control of Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus After Kidney Transplantation

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Lipid-Lowering Drugs and Risk of New-Onset Diabetes: A Cohort Study Using Japanese Healthcare Data Linked to Clinical Data for Health Screening

BMJ Open
Medicine
2017English

Glycemic Control in Type 2 Diabetes Mellitus Patients

Chattagram Maa-O-Shishu Hospital Medical College Journal
2012English

Genetic Determinants of Glycemic Traits and the Risk of Gestational Diabetes Mellitus

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus

Journal of Clinical Medicine Research
2018English

Effect of Legumes as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus

Archives of Internal Medicine
2012English

Permanent Neonatal Diabetes Mellitus: Same Mutation, Different Glycemic Control With Sulfonylurea Therapy on Long-Term Follow-Up

JCRPE Journal of Clinical Research in Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2012English

High Level of Individual Lipid Profile and Lipid Ratio as a Predictive Marker of Poor Glycemic Control in Type-2 Diabetes Mellitus

Vascular Health and Risk Management
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy